Literature DB >> 20020250

Topographical alteration in the cornea after photodynamic therapy for neovascularization in lipid keratopathy.

Tsutomu Igarashi1,2, Chiemi Yaguchi3, Michinori Inage3, Hisaharu Suzuki3, Hiroshi Takahashi3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20020250     DOI： 10.1007/s10384-009-0739-7

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN： 0021-5155            Impact factor:   2.447


× No keyword cloud information.
  4 in total

1.  Photodynamic therapy with verteporfin for corneal neovascularization.

Authors:  Kyung-Chul Yoon; In-Cheon You; In-Seong Kang; Seong-Kyu Im; Jae-Kyoun Ahn; Yeoung-Geol Park; Kyu Youn Ahn
Journal:  Am J Ophthalmol       Date:  2007-07-16       Impact factor: 5.258

Review 2.  Corneal vascularization.

Authors:  B E Caffery; J E Josephson
Journal:  Optom Clin       Date:  1995

3.  Experimental inhibition of corneal neovascularization by photodynamic therapy with verteporfin.

Authors:  Kyung-Chul Yoon; Kyu Youn Ahn; Song Eun Lee; Kyung Keun Kim; Seong-Kyu Im; Han-Jin Oh; In-Young Jeong; Sang-Woo Park; Yeoung-Geol Park; Hyeon-Ju Nah; Wook-Bin Im
Journal:  Curr Eye Res       Date:  2006-03       Impact factor: 2.424

4.  Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization.

Authors:  Mike P Holzer; Kerry D Solomon; David T Vroman; Helga P Sandoval; Philippe Margaron; Terrance J Kasper; Craig E Crosson
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-07       Impact factor: 4.799
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.